All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
The SEC told Gilead Sciences Inc., of Foster City, Calif., and Vertex Pharmaceuticals Inc., of Cambridge, Mass., they could not block shareholders from voting on proposals asking for greater transparency around the management and mitigation of the business risks from rapidly increasing U.S. drug prices.